PubRank

Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD (SPIRO-CKD)

Clinical Trial ID NCT02502981

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02502981

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 49.19
2 Prevalence of chronic kidney disease in the United States. JAMA 2007 38.98
3 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999 29.32
4 Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999 7.17
5 Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2005 3.18
6 Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006 2.80
7 Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol 2009 2.30
8 Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 2000 2.15
9 Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements. J Hypertens 2003 1.74
10 Aldosterone and vascular inflammation. Hypertension 2008 1.65
11 Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000 1.50
12 Arterial stiffness in chronic kidney disease: causes and consequences. Heart 2010 1.29
13 Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction. Heart 2008 1.28
14 Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease. Am J Cardiol 2010 0.93
15 Aldosterone: cardiovascular assault. Am Heart J 2002 0.83
16 Aortic distensibility is closely related to the progression of left ventricular hypertrophy in patients receiving hemodialysis. Angiology 2000 0.79
Next 100